Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

Jairo A. Garcia; Lewis R. Roberts

doi:10.1016/j.jhep.2011.07.033

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

Jairo A. Garcia, Lewis R. Roberts

Gastroenterology and Hepatology

Research output: Contribution to journal › Comment/debate › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	486-487
Number of pages	2
Journal	Journal of hepatology
Volume	56
Issue number	2
DOIs	https://doi.org/10.1016/j.jhep.2011.07.033
State	Published - Feb 2012

ASJC Scopus subject areas

Hepatology

Access to Document

10.1016/j.jhep.2011.07.033

Cite this

@article{37b0de0ebfa24a16934e1445160b8a34,

title = "Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma",

author = "Garcia, {Jairo A.} and Roberts, {Lewis R.}",

year = "2012",

month = feb,

doi = "10.1016/j.jhep.2011.07.033",

language = "English (US)",

volume = "56",

pages = "486--487",

journal = "Journal of hepatology",

issn = "0168-8278",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

AU - Garcia, Jairo A.

AU - Roberts, Lewis R.

PY - 2012/2

Y1 - 2012/2

UR - http://www.scopus.com/inward/record.url?scp=84855979959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855979959&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2011.07.033

DO - 10.1016/j.jhep.2011.07.033

M3 - Comment/debate

C2 - 21963517

AN - SCOPUS:84855979959

SN - 0168-8278

VL - 56

SP - 486

EP - 487

JO - Journal of hepatology

JF - Journal of hepatology

IS - 2

ER -

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this